Lower percentages of monocytes with CD80, CD86 and HLA-DR molecule expression in pediatric cancer

By Luczynski Wlodzimierz   Stasiak-Barmuta Anna   Krawczuk-Rybak Maryna  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 1049-1050

Springer Publishing Company

Access to resources Recommend Favorite

Cytokines IL-1α, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: restoration by interferon γ

By Thomas Giovana   Chen Zhong   Leukinova Elena   Waes Carter   Wen Judy  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 1, 2004-01 ,pp. : 33-40

Springer Publishing Company

Access to resources Recommend Favorite

Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients

By Ugurel Selma   Uhlig Dario   Pföhler Claudia   Tilgen Wolfgang   Schadendorf Dirk   Reinhold Uwe  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 551-559

Springer Publishing Company

Access to resources Recommend Favorite

Continuous expression of CD83 on activated human CD4+ T cells is correlated with their differentiation into induced regulatory T cells

By            

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3309-3314

Spandidos Publications

Access to resources Recommend Favorite

CD80 (B7.1) and CD86 (B7.2) induce EBV-transformed B cell apoptosis through the Fas/FasL pathway

By            

International Journal of Oncology, Vol. 43, Iss. 5, 2013-01 ,pp. : 1531-1540

Spandidos Publications

Access to resources Recommend Favorite